Novavax Inc. (NVAX) announced after the bell Tuesday that its RSV F-protein recombinant nanoparticle vaccine candidate was highly immunogenic in a guinea pig model of maternal immunization. The stock is now up 0.43 on 57K shares.
Novavax climbed during the first half of the morning Tuesday and advanced further in the final 90 minutes of trade. The stock finished with a gain of 0.42 at $10.17.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.